About Us Direct to You Research Archives Currencies Shares Media
Monitoring Home

PRODUCT PROFILE

Latest Dublin Prices

NAME	LATEST	CHANGE
Aer Lingus	1.55	-0.01	more
BoI	0.19	0.00	more
CRH	16.26	-0.15	more
Elan	9.53	0.06	more
Glanbia	10.80	0.00	more
Grafton	5.65	0.11	more
Greencore	0.64	-0.02	more
Ind. News	0.12	0.01	more
Ryanair	6.74	-0.01	more

Shares in full

J and J's earnings beat forecasts

Tuesday, October 16 14:39:37

Johnson and Johnson reported better than expected quarterly results today, as its pharmaceutical sales rebounded with the help of newer products, including treatments for prostate cancer and hepatitis C.

The company earned $3.0 billion, or $1.05 per share, in the third quarter. That compared with $3.2 billion, or $1.15 per share, in the year-earlier period.

Excluding special items, the diversified healthcare company earned $1.25 per share. Analysts, on average, had expected $1.21 per share, according to Thomson Reuters I/B/E/S.

Company revenue rose 6.5 percent to $17.1 billion, topping Wall Street expectations of $16.98 billion.

Business World is a service of Media World Ltd. All rights reserved. While every effort has been made to ensure the accuracy of the data provided, neither Media World Ltd nor its agents or representatives will be responsible for any loss or damage on the part of users however caused. The service is for entertainment only, and no decisions, particularly investment decisions, should be taken on the basis of information supplied in the service.